Trastuzumab-102114.jpg When added to chemotherapy for breast cancer treatment, Herceptin (trastuzaumab) has proven to improve survival rates, according to research conducted at he Mayo Clinic in Jacksonville. The study, published in the Journal of Clinical Oncology, surveyed data on over 4,000 women with breast cancer, one half got chemo, while the other half got chemo with one year of treatment with Herceptin.

laxativetype-101014.jpg Fiber based laxatives have been linked to a decreased risk of colon cancer, according to research conducted at the Fred Hutchinson Cancer Research Center in Seattle. The study, published in The American Journal of Gastroenterology, surveyed data on more than 75,000 adults aged 50 to 76. "I wouldn't necessarily jump the gun and say because of this study, people should stop taking stimulant . . ."

Tobacco-100814.jpg Those who smoke cigarettes and use chewing tobacco face a greater risk of infection with oral human papillomavirus type 16 (HPV16), according to research conducted at Johns Hopkins University. The study, published in JAMA, surveyed data on 6,887 adults (aged 18-59) who had been tested for HPV, reported tobacco use, and had given blood and urine samples for tobacco and nicotine testing.

image3-100714.jpg Many people who are diagnosed with cancer also struggle with depression and anxiety, according to research conducted at the University of Leipzig. The study, published in the Journal of Clinical Oncology, based its findings on interviews with over 2,100 Germans (aged 18-75) with cancer. The team found that 32 percent of patients diagnosed with cancer wound up with a psychological disorder.

breastfeeding-093014.jpg Black mothers who choose to not breastfeed may be at a higher risk of breast cancer than those who do, according to research conducted at Boston University's Slone Epidemiology Center. The study, published in the Journal of the National Cancer Institute, surveyed data on nearly 3,700 black breast cancer patients.

chokeberry-091914.jpg The extract of a wild berry native to North America may strengthen the effectiveness of a chemotherapy drug commonly used to treat pancreatic cancer, according to a new study. Research, published online in the Journal of Clinical Pathology, suggests that adding nutraceuticals to chemotherapy cycles may improve the effectiveness of conventional drugs, particularly in hard to treat cancers.

diaebtes-091014.jpg Prediabetes increases the risk of cancer by 15 percent, according to research conducted at the First People's Hospital of Shunde, China. The meta-analysis, published in the journal Diabetologia, looked at 16 studies, surveying nearly 900,000 people. The team found the greatest link in cancers that occur in the liver, stomach, pancreas, breast and endometrium.

kidney-012513.jpg Thyroid and kidney cancer rates are on the rise in U.S. kids, according to research conducted by the CDC. The study, published in the journal Pediatrics, found that from 2001-2009 there were about 120,000 new cancer diagnoses among infants and children aged 1-19. One particular type of kidney cancer - renal carcinoma - saw an average increase of 5.4 percent per year over the past ten years.

MelanomaTreatment-070113.jpg The FDA has approved Keytruda, a drug manufactured by Merk & Co. Inc. to treat patients with advanced stages of melanoma. Keytruda was tested on 600 patients with advanced forms of melanoma with the majority showing significant improvement. "Keytruda is the sixth new melanoma treatment approved since 2011, a result of promising advances in melanoma research," says the FDA's Dr. Richard Pazdur.